• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus.2 型糖尿病患者的危险因素控制与心血管事件。
PLoS One. 2024 Feb 29;19(2):e0299035. doi: 10.1371/journal.pone.0299035. eCollection 2024.
2
Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.在一级和二级预防环境中,2 型糖尿病患者的危险因素控制与心血管事件风险。
Circulation. 2020 Nov 17;142(20):1925-1936. doi: 10.1161/CIRCULATIONAHA.120.046783. Epub 2020 Nov 16.
3
Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS.睡眠障碍与新发 2 型糖尿病患者心血管疾病和全因死亡率的相关性:来自韩国 NHIS-HEALS 的数据。
Cardiovasc Diabetol. 2020 May 13;19(1):61. doi: 10.1186/s12933-020-01032-5.
4
Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.2 型糖尿病患者的心血管事件和血管介入发生率。
Int J Cardiol. 2017 Dec 1;248:301-307. doi: 10.1016/j.ijcard.2017.07.081. Epub 2017 Jul 23.
5
All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.根据 2 型糖尿病状态和已确立的心血管疾病,对西班牙高龄人群的全因死亡率和心血管事件进行分析。
BMC Geriatr. 2022 Mar 18;22(1):224. doi: 10.1186/s12877-022-02893-z.
6
Changes in behaviors after diagnosis of type 2 diabetes and 10-year incidence of cardiovascular disease and mortality.2 型糖尿病诊断后行为变化与心血管疾病 10 年发生率和死亡率的关系。
Cardiovasc Diabetol. 2019 Aug 1;18(1):98. doi: 10.1186/s12933-019-0902-5.
7
Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.利用健康保险理赔数据开发 2 型糖尿病患者主要不良心血管事件的预测风险模型。
Cardiovasc Diabetol. 2018 Aug 24;17(1):118. doi: 10.1186/s12933-018-0759-z.
8
The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.基线风险对2型糖尿病合并有症状心血管疾病患者糖化血红蛋白(HbA1c)与新发心血管事件风险及死亡率之间关系的影响。
Cardiovasc Diabetol. 2016 Jul 19;15(1):101. doi: 10.1186/s12933-016-0418-1.
9
Correlation between the Variability of Glycosylated Hemoglobin and Cardiovascular Risk in New-Onset T2DM Patients.初诊 2 型糖尿病患者糖化血红蛋白变异性与心血管风险的相关性。
Contrast Media Mol Imaging. 2022 Mar 11;2022:5370301. doi: 10.1155/2022/5370301. eCollection 2022.
10
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.心脏-肾脏-代谢合并症对 2 型糖尿病患者心血管结局和死亡率的影响。
Am J Nephrol. 2020;51(1):74-82. doi: 10.1159/000504558. Epub 2019 Dec 6.

引用本文的文献

1
Quality of hospital and follow-up care among patients with type 2 diabetes and newly diagnosed cardiovascular disease: a cohort study in Sweden.2型糖尿病合并新诊断心血管疾病患者的医院及后续护理质量:瑞典的一项队列研究
BMJ Open. 2025 Jun 23;15(6):e096633. doi: 10.1136/bmjopen-2024-096633.
2
Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram.2型糖尿病患者高血压风险预测模型的构建:独立危险因素与列线图
World J Diabetes. 2025 May 15;16(5):102141. doi: 10.4239/wjd.v16.i5.102141.
3
Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis.通过纵向临床数据库分析探讨SGLT-2抑制剂对2型糖尿病患者心力衰竭的保护作用
J Clin Med. 2024 Nov 24;13(23):7093. doi: 10.3390/jcm13237093.
4
Analysis of the Associations of Measurements of Body Composition and Inflammatory Factors with Cardiovascular Disease and Its Comorbidities in a Community-Based Study.一项基于社区的研究中身体成分测量与炎症因子与心血管疾病及其合并症的关联分析
Biomedicines. 2024 May 11;12(5):1066. doi: 10.3390/biomedicines12051066.

本文引用的文献

1
Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.韩国 2 型糖尿病患者的低密度脂蛋白胆固醇目标达标现状与近期指南比较。
Diabetes Metab J. 2021 May;46(3):464-475. doi: 10.4093/dmj.2021.0088. Epub 2022 Mar 3.
2
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022.9. 血糖治疗的药物学方法:《2022 年糖尿病医学诊疗标准》。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S125-S143. doi: 10.2337/dc22-S009.
3
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022.10. 心血管疾病和风险管理:2022 年糖尿病医学护理标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S144-S174. doi: 10.2337/dc22-S010.
4
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.降低2型糖尿病心血管风险的降糖药物
N Engl J Med. 2021 Apr 1;384(13):1248-1260. doi: 10.1056/NEJMcp2000280.
5
Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea.韩国糖尿病患者心血管并发症和死亡率的趋势。
Diabetes Metab J. 2021 Jan;45(1):120-124. doi: 10.4093/dmj.2020.0175. Epub 2020 Dec 9.
6
Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.在一级和二级预防环境中,2 型糖尿病患者的危险因素控制与心血管事件风险。
Circulation. 2020 Nov 17;142(20):1925-1936. doi: 10.1161/CIRCULATIONAHA.120.046783. Epub 2020 Nov 16.
7
Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study.糖尿病与特定病因死亡率:一项基于人群的研究。
Diabetes Metab J. 2019 Jun;43(3):319-341. doi: 10.4093/dmj.2018.0060.
8
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study.强化多因素干预对卒中风险的有益影响:随机 Steno-2 研究 21 年随访结果。
Diabetologia. 2019 Sep;62(9):1575-1580. doi: 10.1007/s00125-019-4920-3. Epub 2019 Jun 1.
9
Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants.亚洲人群中糖尿病与全因及特定原因死亡率的相关性:一项超过 100 万参与者的汇总分析。
JAMA Netw Open. 2019 Apr 5;2(4):e192696. doi: 10.1001/jamanetworkopen.2019.2696.
10
Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus.血压与 2 型糖尿病韩国患者心血管疾病的发展。
Hypertension. 2019 Feb;73(2):319-326.

2 型糖尿病患者的危险因素控制与心血管事件。

Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus.

机构信息

Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

出版信息

PLoS One. 2024 Feb 29;19(2):e0299035. doi: 10.1371/journal.pone.0299035. eCollection 2024.

DOI:10.1371/journal.pone.0299035
PMID:38422102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10903792/
Abstract

BACKGROUND

Since patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events, interventions addressing risk factors reduce the incidence of cardiovascular disease (CVD) events. This study aimed to evaluate the difference in the incidence of CVD events according to risk factor control in patients with diabetes with and without cardio-renal disease.

METHODS

We analyzed 113,909 patients with diabetes and 290,339 without diabetes using data released by the National Health Insurance Service (NHIS).

RESULTS

Among patients with diabetes with four or five poorly controlled risk factors, hazard ratio for CVD events was 1.19 (95% confidence interval [CI], 1.06-1.34) in patients with cardio-renal disease and 2.31 (95% CI, 1.95-2.74) in patients without cardio-renal disease compared to patients with diabetes without risk factors. In subjects with diabetes and cardio-renal disease, patients with four or five poorly controlled risk factors had a higher risk of CVD mortality compared to subjects without risk factors (hazard ratio, 1.64; 95% CI, 1.18-2.30).

CONCLUSION

Controlling cardiovascular risk factors reduced the incidence of CVD events in patients with diabetes, especially those without cardio-renal disease. The degree of risk control was strongly associated with CVD mortality in patients with diabetes with baseline cardio-renal disease.

摘要

背景

由于 2 型糖尿病(T2DM)患者发生心血管事件的风险增加,因此针对风险因素的干预措施可降低心血管疾病(CVD)事件的发生率。本研究旨在评估有和无心肾疾病的糖尿病患者,根据危险因素控制情况,CVD 事件的发生率有无差异。

方法

我们使用国民健康保险服务(NHIS)发布的数据,对 113909 例糖尿病患者和 290339 例非糖尿病患者进行了分析。

结果

在伴有四或五项控制不佳的危险因素的糖尿病患者中,与无危险因素的患者相比,伴有心肾疾病的患者 CVD 事件的风险比为 1.19(95%置信区间[CI],1.06-1.34),而无心肾疾病的患者为 2.31(95%CI,1.95-2.74)。在伴有心肾疾病的糖尿病患者中,与无危险因素的患者相比,伴有四或五项控制不佳的危险因素的患者 CVD 死亡率更高(风险比,1.64;95%CI,1.18-2.30)。

结论

控制心血管危险因素可降低糖尿病患者的 CVD 事件发生率,尤其是无心肾疾病的患者。在伴有心肾疾病的糖尿病患者中,风险控制程度与 CVD 死亡率密切相关。